We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Prior Authorization Software for Imaging Centers Launched at RBMA 2015

By MedImaging International staff writers
Posted on 16 Jun 2015
A major supplier of healthcare financial process automation has announced the launch of a novel automated prior authorization system, which can save imaging centers costs and time.

The software was launched at the Radiology Business Management Association (RBMA; Las Vegas, NV, USA) Radiology summit in June, 2015.

The AuthPal software made by FORE Support Services (El Paso, TX, USA) reduces the time to process a radiology prior authorization from days to hours or minutes, saving time and costs.

The technology is secured using a US Health Insurance Portability and Accountability Act (HIPAA) compliant cloud platform with Secure Sockets Layer (SSL) and AES 256 bit encryption. The AuthPal software checks if a prior authorization is needed, and obtains the latest status and all necessary data.

FORE Support Services president and CEO Mohammed M. Ahmed, said, “AuthPal represents breakthrough technology specifically developed to address the costs and headaches associated with prior authorizations. We’ve automated the entire process, eliminating costly denials and reducing labor costs, which will change the way imaging centers and radiology practices handle prior authorizations.”

Related Links:

Fore Support Services
AuthPal


Multi-Use Ultrasound Table
Clinton
Biopsy Software
Affirm® Contrast
40/80-Slice CT System
uCT 528
Half Apron
Demi

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.